TMO - Thermo Fisher Scientific (TMO) COMMON
This page shows which of the focused investors we track hold TMO and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2011 it was held by 6 managers with an aggregate reported value of $62.67M, which is 0.01% of the combined portfolio.
As of Q2 2011, 6 tracked institutional managers held TMO (Thermo Fisher Scientific (TMO) COMMON) with an aggregate reported value of $62.67M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades TMO — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2011
- Ticker
- TMO
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Greenhaven Associates - Greenhaven Associates | 1.34% | Reduce -57.6% | 682,380 | $43.94M |
| 2 | Dodge & Cox - Dodge & Cox | 0.01% | Reduce -12.1% | 150,652 | $9.7M |
| 3 | Robert Olstein - Olstein Capital Management | 1.04% | Reduce -34.7% | 98,000 | $6.31M |
| 4 | David Katz - Matrix Asset Advisors | 0.27% | - | 36,020 | $2.32M |
| 5 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.01% | New | 6,105 | $393K |
| 6 | First Eagle - First Eagle Investment Management | 0.00% | - | 200 | $13K |
Loading holder history for TMO…